A persistent question hangs over RTX Corp (NYSE: RTX): whether a defense and aerospace giant with a historically underwhelming return on invested capital deserves its current premium price tag.

RTX’s five-year average ROIC stands at just 5.3%, a figure that looks modest against the best industrials operators, which routinely generate returns exceeding 20%.

That capital efficiency gap matters because it reflects how productively the company has deployed the debt and equity raised to fund its growth ambitions over the long term.

Yet the near-term picture tells a more encouraging story, with shares climbing 11.1% over the past six months to reach $195.17, comfortably ahead of the S&P 500’s 7.5% gain across the same stretch.

The company, which traces its origins to refrigeration technology before pivoting to serve aerospace and defense markets, has built a business generating consistent organic revenue momentum.

Organic revenue growth, which strips out acquisitions, divestitures, and foreign currency swings to isolate core operational performance, averaged 11% year-on-year across the last two years.

That kind of top-line expansion, achieved without leaning on deal-making, signals genuine commercial traction in the defense procurement cycle rather than financial engineering.

Equally compelling is what has happened to RTX’s free cash flow profile, a metric that captures all operating and capital costs and is therefore considerably harder to flatter than reported earnings.

The company’s free cash flow margin expanded by 4.9 percentage points over the past five years, finishing the trailing twelve-month period at 9.9%, a trajectory that suggests a structurally less capital-intensive business model is taking shape.

The combination of rising cash generation and above-market share price performance has brought RTX to a forward price-to-earnings multiple of 25.4 times, a valuation that prices in continued execution but leaves limited room for operational stumbles.

Investors weighing a position must therefore reconcile two competing signals: a business firing on all cylinders operationally, set against a long-run capital allocation track record that has historically failed to match the standards of the sector’s top performers.

Whether the recent improvements in free cash flow margin and organic growth represent a durable shift in the company’s capital efficiency, or merely a favorable cycle, is ultimately the central question for anyone considering RTX at current levels.